Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
35,82 € ↓ -1,80 (-4,78%)
2026-06-05
DEL PRIS
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionEukles Asset Management
Latest Disclosed Ownership50,927 shares
Latest Disclosed Value $ 1,871,604
Eukles Asset Management reports 3.79% decrease in ownership of NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On May 5, 2026 - Eukles Asset Management filed a 13F-HR form disclosing ownership of 50,927 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $1,606,747 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 52,933 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of -3.79% during the quarter. The current value of the position is $1,824,205 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F Novo Nordisk A Common Stock 670100205 50,927 -2,006 -3.79 1,872 -30.52 0.8344
2026-02-09 2025-12-31 13F Novo Nordisk A Common Stock 670100205 52,933 0 0.00 2,693 -8.31 1.0472
2025-11-05 2025-09-30 13F Novo Nordisk A Common Stock 670100205 52,933 -782 -1.46 2,937 -20.77 1.1437
2025-08-06 2025-06-30 13F Novo Nordisk A Common Stock 670100205 53,715 2,403 4.68 3,707 4.04 1.5161
2025-04-29 2025-03-31 13F Novo Nordisk A Common Stock 670100205 51,312 1,667 3.36 3,563 -16.56 1.5635
2025-01-29 2024-12-31 13F Novo Nordisk A Common Stock 670100205 49,645 -3,939 -7.35 4,270 -33.07 1.8194
2024-10-29 2024-09-30 13F Novo Nordisk A Common Stock 670100205 53,584 -371 -0.69 6,380 -17.15 2.5609
2024-08-01 2024-06-30 13F Novo Nordisk A Common Stock 670100205 53,955 -378 -0.70 7,702 10.39 3.3326
2024-05-13 2024-03-31 13F NOVO NORDISK Common Stock 670100205 54,333 -1,598 -2.86 6,976 20.57 3.0337
2024-01-31 2023-12-31 13F Novo Nordisk A Common Stock 670100205 55,931 -2,754 -4.69 5,786 8.43 2.7356
2023-10-25 2023-09-30 13F Novo Nordisk A Common Stock 670100205 58,685 29,550 101.42 5,337 13.19 2.8180
2023-08-01 2023-06-30 13F Novo Nordisk A Common Stock 670100205 29,135 29 0.10 4,715 1.79 2.4108
2023-04-28 2023-03-31 13F Novo Nordisk A Common Stock 670100205 29,106 -270 -0.92 4,632 154,266.67 2.5188
2023-01-27 2022-12-31 13F Novo Nordisk A Common Stock 670100205 29,376 204 0.70 4 -99.90 2.3207
2022-10-28 2022-09-30 13F NOVO NORDISK Common Stock 670100205 29,172 -93 -0.32 2,906 -10.89 1.9040
2022-07-28 2022-06-30 13F Novo Nordisk A Common Stock 670100205 29,265 91 0.31 3,261 0.65 2.0644
2022-04-27 2022-03-31 13F Novo Nordisk A Common Stock 670100205 29,174 -329 -1.12 3,240 -1.94 1.7615
2022-02-10 2021-12-31 13F Novo Nordisk A Common Stock 670100205 29,503 560 1.93 3,304 18.89 1.5987
2021-10-28 2021-09-30 13F Novo Nordisk A Common Stock 670100205 28,943 995 3.56 2,779 18.71 1.5205
2021-07-27 2021-06-30 13F Novo Nordisk A Common Stock 670100205 27,948 1,993 7.68 2,341 33.77 1.2975
2021-04-27 2021-03-31 13F Novo Nordisk A Common Stock 670100205 25,955 561 2.21 1,750 -1.35 1.1317
2021-01-26 2020-12-31 13F NOVO NORDISK Common Stock 670100205 25,394 602 2.43 1,774 3.08 1.2267
2020-10-29 2020-09-30 13F NOVO NORDISK Common 670100205 24,792 299 1.22 1,721 7.36 1.3395
2020-07-29 2020-06-30 13F Novo Nordisk A Common 670100205 24,493 1,447 6.28 1,603 15.57 1.3643
2020-04-22 2020-03-31 13F Novo Nordisk A Common 670100205 23,046 -1,041 -4.32 1,387 -0.50 1.4452
2020-01-24 2019-12-31 13F Novo Nordisk A Common 670100205 24,087 -247 -1.02 1,394 10.81 1.1357
2019-10-29 2019-09-30 13F Novo Nordisk A Common 670100205 24,334 -69 -0.28 1,258 0.96 1.0898
2019-08-01 2019-06-30 13F NOVO NORDISK Common 670100205 24,403 -119 -0.49 1,246 -2.88 1.0834
2019-04-23 2019-03-31 13F Novo Nordisk A Common 670100205 24,522 98 0.40 1,283 14.04 1.1704
2019-01-22 2018-12-31 13F Novo Nordisk A Common 670100205 24,424 24,424 1,125 1.1728
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.